Publication | Open Access
Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial
20
Citations
29
References
2017
Year
Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukaemiaMedicineHematologyClinical TrialsPathologyPharmacotherapySymptom ControlPhase 2OncologyCancer ResearchHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1